4.7 Article

Concordance Between Genomic Alterations Detected by Tumor and Germline Sequencing: Results from a Tertiary Care Academic Center Molecular Tumor Board

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021

Mary B. Daly et al.

Summary: The NCCN Guidelines focus on assessing genetic variants associated with increased risk of breast, ovarian, and pancreatic cancer, particularly BRCA-related breast/ovarian cancer syndrome and Li-Fraumeni syndrome. Individuals with pathogenic BRCA1/2 variants have high risks of breast and ovarian cancer, as well as elevated risks of prostate cancer and pancreatic cancer. Li-Fraumeni syndrome is associated with high lifetime risks of various cancers.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)

Review Oncology

Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis

Raffaella Casolino et al.

Summary: The study analyzed the prevalence of HRD in PDAC patients, finding that surrogate markers of HRD identified more patients than gene-level approaches. There is a need to harmonize HRD definitions and validate the optimal biomarker for treatment selection. Universal HRD screening, including integrated somatic and germline analysis, should be offered to all PDAC patients.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

Implementation of a Molecular Tumor Registry to Support the Adoption of Precision Oncology Within an Academic Medical Center: The Duke University Experience

Michelle F. Green et al.

Summary: Comprehensive genomic profiling is essential in oncology care but can be challenging for oncologists to interpret. The Molecular Registry of Tumors (MRT) and Molecular Tumor Board (MTB) provide a solution by aggregating genomic data and facilitating targeted therapy selection. Through MRT, therapeutic sensitivity, resistance alterations, and potential germline implications can be identified, ultimately improving precision cancer medicine programs.

JCO PRECISION ONCOLOGY (2021)

Article Medicine, General & Internal

Olaparib for Metastatic Castration-Resistant Prostate Cancer

J. de Bono et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer

Talia Golan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Letter Pathology

Identification of Germline Variants in Tumor Genomic Sequencing Analysis

Nathan D. Montgomery et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2018)

Article Medicine, General & Internal

Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation

Jennifer K. Litton et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Medicine, General & Internal

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

K. Moore et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Medicine, General & Internal

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

Mark Robson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Oncology

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA

Kasmintan A. Schrader et al.

JAMA ONCOLOGY (2016)

Review Andrology

The role of BRCA1 and BRCA2 in prostate cancer

Elena Castro et al.

ASIAN JOURNAL OF ANDROLOGY (2012)

Article Computer Science, Interdisciplinary Applications

Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support

Paul A. Harris et al.

JOURNAL OF BIOMEDICAL INFORMATICS (2009)

Review Cell Biology

Homologous recombination in DNA repair and DNA damage tolerance

Xuan Li et al.

CELL RESEARCH (2008)